Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis

about

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2

P2860

Q36145180-EE91CC08-05F6-47EE-8D23-9226C33E7EB0

P2860

Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis

Item

http://www.wikidata.org/entity/Q35764402

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Systematic Review of the Assoc ...... olipase A2 and Atherosclerosis

@ast

Systematic Review of the Assoc ...... olipase A2 and Atherosclerosis

@en

type

Item

label

Systematic Review of the Assoc ...... olipase A2 and Atherosclerosis

@ast

Systematic Review of the Assoc ...... olipase A2 and Atherosclerosis

@en

prefLabel

Systematic Review of the Assoc ...... olipase A2 and Atherosclerosis

@ast

Systematic Review of the Assoc ...... olipase A2 and Atherosclerosis

@en

P1476

Systematic Review of the Assoc ...... olipase A2 and Atherosclerosis

@en

P2093

Dong Zhao

http://www.w3.org/2001/XMLSchema#string

Fan Zhao

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Yue Qi

http://www.w3.org/2001/XMLSchema#string

Yuling Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.

Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature

Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes

Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.

Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.

Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women.

P304

201-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7156/V4I4P201

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26339459

http://www.w3.org/2001/XMLSchema#string

P932

4555875

http://www.w3.org/2001/XMLSchema#string

Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis

about

P2860

P2860

Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932